RXO, Inc. (NYSE:RXO) Receives Average Rating of “Hold” from Analysts

RXO, Inc. (NYSE:RXOGet Free Report) has earned a consensus rating of “Hold” from the sixteen research firms that are presently covering the company, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, eleven have assigned a hold recommendation and three have issued a buy recommendation on the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $19.93.

Several equities analysts have issued reports on RXO shares. Barclays cut their target price on RXO from $24.00 to $22.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 2nd. Oppenheimer lowered shares of RXO from an “outperform” rating to a “market perform” rating in a research note on Friday, April 4th. Citigroup lowered their target price on shares of RXO from $23.00 to $15.00 and set a “neutral” rating for the company in a research note on Tuesday, April 8th. Jefferies Financial Group reduced their price target on RXO from $26.00 to $20.00 and set a “buy” rating on the stock in a research report on Friday, April 11th. Finally, Benchmark reissued a “hold” rating on shares of RXO in a research report on Wednesday, January 15th.

Read Our Latest Stock Analysis on RXO

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Barclays PLC grew its position in shares of RXO by 185.5% during the 3rd quarter. Barclays PLC now owns 908,873 shares of the company’s stock valued at $25,449,000 after acquiring an additional 590,530 shares during the period. Wilmington Savings Fund Society FSB acquired a new stake in RXO in the third quarter valued at approximately $28,000. Franklin Resources Inc. acquired a new stake in RXO in the third quarter valued at approximately $22,344,000. Principal Financial Group Inc. raised its stake in shares of RXO by 11.3% during the 3rd quarter. Principal Financial Group Inc. now owns 650,222 shares of the company’s stock worth $18,206,000 after buying an additional 66,159 shares during the period. Finally, JPMorgan Chase & Co. lifted its position in shares of RXO by 71.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 272,062 shares of the company’s stock valued at $7,618,000 after buying an additional 113,685 shares in the last quarter. Hedge funds and other institutional investors own 92.73% of the company’s stock.

RXO Stock Up 0.4 %

NYSE:RXO opened at $14.49 on Friday. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.26 and a quick ratio of 1.33. RXO has a 1-year low of $12.19 and a 1-year high of $32.82. The company has a 50-day moving average of $16.00 and a 200 day moving average of $22.31. The firm has a market cap of $2.38 billion, a PE ratio of -6.83, a price-to-earnings-growth ratio of 4.55 and a beta of 1.71.

RXO (NYSE:RXOGet Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.01). RXO had a positive return on equity of 1.53% and a negative net margin of 6.26%. The business had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.51 billion. During the same period in the previous year, the company posted ($0.03) EPS. RXO’s revenue for the quarter was up 57.0% on a year-over-year basis. As a group, research analysts anticipate that RXO will post 0.31 EPS for the current fiscal year.

About RXO

(Get Free Report

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Recommended Stories

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.